The UK is witnessing a significant surge in interest surrounding entheogenic substances. Beyond the familiar use of psilocybin and LSD, scientists and explorers are increasingly exploring less-charted areas, particularly the copyright compound and the nascent cannabinoid, CBG. The evolving movement